Skip to main content
Log in

Characterization of a monoclonal antibody directed against the epidermal growth factor receptor binding site

  • Original articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

In this work a new monoclonal antibody (mAb), designated MGR1, which recognizes the epidermal growth factor receptor (EGF-R) binding site, is described. The main characteristic of this mAb is its ability to discriminate between cells that express normal levels of EGF-R from cells with overexpression, the detectability threshold by immunocytochemical tests being 5 × 104 receptors/cell of 10 µm diameter. MGR1 was found to inhibit EGF binding on the relevant target cells, and vice versa its binding was inhibited by EGF, which indicated that MGR1 recognizes the EGF receptor binding site. MGR1 exerted an inhibitory effect on both the in vitro and in vivo growth of cells with EGF-R overexpression, but had no effect on cells with a normal expression of the receptor. Tumour growth inhibition in athymic mice was also obtained on already implanted tumours. MGR1 therefore seems to be an adequate reagent for the development of immunotherapeutical approaches suitable for the treatment of tumours with EGF-R overexpression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Abound-Pirak E, Hurwitz E, Pirak ME, Bellot F, Schlessinger J, Sela M (1988) Efficacy of antibodies to epidermal growth factor receptor against KB carcinoma in vitro and in nude mice. J Natl Cancer Inst 80: 1605

    PubMed  Google Scholar 

  2. Abound-Pirak E, Hurwitz E, Bellot F, Schlessinger J, Sela M (1989) Inhibition of human tumour growth in nude mice by a conjugate of doxorubicin with monoclonal antibodies to epidermal growth factor receptor. Proc Natl Acad Sci USA 86: 3778

    PubMed  Google Scholar 

  3. Canevari S, Orlandi R, Ripamonti M, Tagliabue E, Aguanno S, Miotti S, Ménard S, Colnaghi MI (1985) Ricin A chain conjugated with monoclonal antibodies selectively killing human carcinoma cells in vitro. J Natl Cancer Inst 75: 831

    PubMed  Google Scholar 

  4. Carpenter G (1987) Receptors for epidermal growth factor and other polypeptide mitogens. Annu Rev Biochem 56: 881

    PubMed  Google Scholar 

  5. DePotter CR, VanDaele S, VanDeVijver MJ, Pauwels C, Maertens G, DeBoever J, Vandekerckhove D, Roels H (1989) The expression of the neu oncogene product in breast lesions and in normal fetal and adult human tissues. Histopathology 15: 362

    Google Scholar 

  6. Ey PL, Prowse SJ, Jenken CR (1978) Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-Sepharose. Immunochemistry 15: 429

    PubMed  Google Scholar 

  7. Fendly BM, Winget M, Hudziak RM, Lipari MT, Napier MA, Ullrich A (1990) Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/neu gene product. Cancer Res 50: 1550

    PubMed  Google Scholar 

  8. Foon KA (1989) Biological response modifiers: the new immunotherapy. Cancer Res 49: 1621

    PubMed  Google Scholar 

  9. Gill GN, Kawamoto T, Cochet C, Le A, Sato JD, Masui H, McLeod C, Mendelsohn J (1984) Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity. J Biol Chem 259: 7755

    PubMed  Google Scholar 

  10. Gullick WJ, Marsden JJ, Whittle N, Ward B, Bobrow L, Waterfield MD (1986) Expression of epidermal growth factor receptors on human cervical ovarian and vulvar carcinomas. Cancer Res 46: 285

    PubMed  Google Scholar 

  11. Harris AL (1990) The epidermal growth factor receptor as a target for therapy. Cancer Cells 2: 321

    PubMed  Google Scholar 

  12. Hendler FJ, Ozane BW (1984) Human squamous cell lung cancers express increased epidermal growth factor receptors. J Clin Invest 74: 647

    PubMed  Google Scholar 

  13. Kalofonos HP, Pawlikowska TR, Hemingway A, Courtenay-Luck N, Dhokia B, Snook D, Sivolapenko GB, Hooker GR, McKenzie CG, Lavender PJ, Thomas DGT, Epenetos AA (1989) Antibody guided diagnosis and therapy of brain gliomas using radiolabeled monoclonal antibodies against epidermal growth factor receptor and placental alkaline phosphatase. J Nucl Med 30: 1636

    PubMed  Google Scholar 

  14. Kamata N, Chida K, Rikimaru K, Horikoshi M, Enomoto S, Kuroki T (1986) Growth-inhibitory effects of epidermal growth factor and overexpression of its receptors on human squamous cell carcinomas in culture. Cancer Res 46: 1648

    PubMed  Google Scholar 

  15. Kawamoto T, Sato JD, Le A, Polikoff J, Sato GH, Mendelsohn J (1983) Growth stimulation of A431 cells by epidermal growth factor: Identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. Proc Natl Acad Sci USA 80: 1337

    PubMed  Google Scholar 

  16. Knowles AF (1988) Inhibition of growth and induction of enzyme activities in a clonal human hepatoma cell line (Li-7A): comparison of the effects of epidermal growth factor receptor antibody. J Cell Physiol 134: 109

    PubMed  Google Scholar 

  17. Laemmli VK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680

    PubMed  Google Scholar 

  18. Libermann TA, Nusbaum HR, Razon N, Kris R, Lax I, Soreq H, Whittle N, Waterfield MD, Ullrich A, Schlessinger J (1985) Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature 313: 144

    PubMed  Google Scholar 

  19. Masui H, Kawamoto T, Sato JD, Wolf B, Sato G, Mendelsohn J (1984) Growth inhibition of human tumour cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies. Cancer Res 44: 1002

    PubMed  Google Scholar 

  20. Masui H, Moroyama T, Mendelsohn J (1986) Mechanism of antitumour activity in mice for anti-epidermal growth factor receptor monoclonal antibodies with different isotypes. Cancer Res 46: 5592

    PubMed  Google Scholar 

  21. Masui H, Kamrath H, Apell G, Houston LL, Mendelsohn J (1989) Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain. Cancer Res 49: 3482

    PubMed  Google Scholar 

  22. Ménard S, Tagliabue E, Canevari S, Fossati G, Colnaghi MI (1983) Generation of monoclonal antibodies reacting with normal and cancer cells of human breast. Cancer Res 43: 1295

    PubMed  Google Scholar 

  23. Miotti S, Canevari S, Ménard S, Mezzanzanica D, Porro G, Pupa SM, Regazzoni M, Tagliabue E, Colnaghi MI (1987) Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumour-restricted specificity. Int J Cancer 39: 297

    PubMed  Google Scholar 

  24. Natali PG, Nicotra MR, Bigotti A, Venturo I, Slamon DJ, Fendly BM, Ullrich A (1990) Expression of the p185 encoded by HER2 oncogene in normal and transformed human tissues. Int J Cancer 45: 457

    PubMed  Google Scholar 

  25. Ozawa S, Ueda M, Ando N, Abe O, Shimizu N (1987) High incidence of EGF receptor hyperproduction in esophageal squamous-cell carcinomas. Int J Cancer 39: 333

    PubMed  Google Scholar 

  26. Ozawa S, Ueda M, Ando N, Abe O, Minoshima S, Shimizu N (1989) Selective killing of squamous carcinoma cells by an immunotoxin that recognizes the EGF receptor. Int J Cancer 43: 152

    PubMed  Google Scholar 

  27. Rodeck U, Herlyn M, Herlyn D, Molthoff C, Atkinson B, Varello M, Steplewski Z, Koprowski H (1987) Tumour growth modulation by a monoclonal antibody to the epidermal growth factor receptor: immunologically mediated and effector cell-independent effects. Cancer Res 47: 3692

    PubMed  Google Scholar 

  28. Sakai K, Mori S, Kawamoto T, Taniguchi S, Kobori O, Morioka Y, Kuroki T and Kano K (1986) Expression of epidermal growth factor receptors on normal human gastric epithelia and gastric carcinomas. J Natl Cancer Inst 77: 1047

    PubMed  Google Scholar 

  29. Sato GH, Sato JD (1989) Growth factor receptor monoclonal antibodies and cancer immunotherapy. J Natl Cancer Inst 81: 1600

    PubMed  Google Scholar 

  30. Schreiber AB, Lax I, Yarden Y, Eshhar Z, Schlessinger J (1981) Monoclonal antibodies against receptor for epidermal growth factor induce early and delayed effect of epidermal growth factor. Proc Natl Acad Sci USA 78: 7535

    PubMed  Google Scholar 

  31. Slamon DJ, Press MF, Godolphin W, Ramos L, Haran P, Shek L, Stuart SG, Ullrich A (1989) Studies of the HER2/neu proto-oncogene in human breast cancer. Cancer Cells 7: 371

    Google Scholar 

  32. Sobol RE, Astarita RW, Hofeditz C, Masui H, Fairshter R, Royston I and Mendelsohn J (1987) Epidermal growth factor receptor expression in human lung carcinomas defined by a monoclonal antibody. J Natl Cancer Inst 79: 403

    PubMed  Google Scholar 

  33. Taetle R, Honeysett JM, Houston LL (1988) Effects of anti-epidermal growth factor (EGF) receptor antibodies and an anti-EGF receptor recombinant-ricin A chain immunoconjugate on growth of human cells. J Natl Cancer Inst 80: 1053

    PubMed  Google Scholar 

  34. Tagliabue E, Ménard S, Della Torre G, Barbanti P, Mariani-Costantini R, Porro G, Colnaghi MI (1985) Generation of monoclonal antibodies reacting with human epithelial ovarian cancer. Cancer Res 45: 379

    PubMed  Google Scholar 

  35. Vollmar AM, Banker DE, Mendelsohn J, Herschman HR (1987) Toxicity of ligand and antibody-directed ricin A chain conjugates recognizing the epidermal growth factor receptor. J Cell Physiol 131: 418

    PubMed  Google Scholar 

  36. Waterfield MD, Mayes EL, Stroobant P, Bennet LPB, Young S, Goodfellow PN, Banting GS, Ozanne B (1982) A monoclonal antibody to the human epidermal growth factor receptor. J Cell Biochem 20: 149

    PubMed  Google Scholar 

  37. Weber W, Gill GN (1984) Production of an epidermal growth factor receptor related-protein. Science 224: 294

    PubMed  Google Scholar 

  38. Weiner DB, Nordberg J, Robinson R, Nowell PC, Gazdar A, Greene MI, Williams Wv, Cohen JA, Kern JA (1990) Expression of theneu gene-encoded protein (p185neu) in human non-small cell carcinomas of the lung. Cancer Res 50: 421

    PubMed  Google Scholar 

  39. Yamamoto T, Kamata N, Kawano H, Shimizu S, Kuroki T, Tayoshima K, Rikimaru K, Nomura N, Ishizaki R, Pastan I, Gamou S, Shimizu N (1986) High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines. Cancer Res 46: 414

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pellegrini, R., Centis, F., Martignone, S. et al. Characterization of a monoclonal antibody directed against the epidermal growth factor receptor binding site. Cancer Immunol Immunother 34, 37–42 (1991). https://doi.org/10.1007/BF01741322

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01741322

Key words

Navigation